Dara-CyBorD vs CyBorD in Newly Diagnosed AL Amyloidosis| Hans Lee, MD | #ASH2024

Dr Hans Lee gives an update on therapies for newly diagnosed AL amyloidosis patients.

Link to ASH playlist: https://healthtree.org/blood-c....ancer/university/mod

ASH Abstract: Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study
#ASH24 #Myeloma #mmsm

Follow HealthTree: https://linktr.ee/HealthTreeUniversity